Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, January 3, 2023
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
Fri, December 30, 2022
[ Fri, Dec 30th 2022
] - WOPRAI
[ Fri, Dec 30th 2022
] - WOPRAI
[ Fri, Dec 30th 2022
] - WOPRAI
[ Fri, Dec 30th 2022
] - WOPRAI
Thu, December 29, 2022
[ Thu, Dec 29th 2022
] - WOPRAI
[ Thu, Dec 29th 2022
] - WOPRAI
[ Thu, Dec 29th 2022
] - WOPRAI
[ Thu, Dec 29th 2022
] - WOPRAI
[ Thu, Dec 29th 2022
] - WOPRAI
[ Thu, Dec 29th 2022
] - WOPRAI
[ Thu, Dec 29th 2022
] - WOPRAI
Ed Arce Maintained (TERN) at Hold with Increased Target to $7 on, Dec 29th, 2022
Ed Arce of HC Wainwright & Co., Maintained "Terns Pharmaceuticals, Inc." (TERN) at Hold with Increased Target from $6 to $7 on, Dec 29th, 2022.
Ed has made no other calls on TERN in the last 4 months.
There is 1 other peer that has a rating on TERN. Out of the 1 peers that are also analyzing TERN, 0 agree with Ed's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ed
- Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $14 on, Tuesday, December 20th, 2022
